ClearBridge LLC (Maryland)’s CareDx CDNA Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,300	Closed	-$38K	–	92
2018 Q3	$38K	Buy	+1,300	New	+$24.3K	0.01%	86

Other funds holding CDNA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ClearBridge LLC (Maryland)'s CDNA Position: Q4 2018 in Review

ClearBridge LLC (Maryland) sold out of CareDx (CDNA) in Q4 2018, closing a stake of 1,300 shares — an estimated $38K sold.

ClearBridge LLC (Maryland) first reported a position in CDNA in Q3 2018 and held it in 1 quarter. The position peaked at $38K in Q3 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

ClearBridge LLC (Maryland) reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
ClearBridge LLC (Maryland) sold 1,300 CareDx shares in Q4 2018, an estimated $38K.
ClearBridge LLC (Maryland) first reported a position in CareDx in Q3 2018 and held it in 1 quarter.
ClearBridge LLC (Maryland)'s CareDx position peaked at $38K in Q3 2018.
148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.